Search for: "Genentech, Inc. et al v. Amgen Inc." Results 1 - 11 of 11
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Judge Sleet Grants Amgen’s Motion to Dismiss Genetech’s Commercial Marketing Claim Without Prejudice
20 Apr 2018, 8:51 am by Gregory B. Williams
Sleet in Genentech, Inc. et al. v. [read post]
Delaware Intellectual Property Litigation - http://delawareintellectualproperty.foxrothschild.com/
Judge Sleet Denies Amgen’s Motion to Transfer Infringement Action to California
27 Jan 2018, 6:40 am by Gregory B. Williams
Sleet in Genentech, Inc. et al. v. [read post]
Delaware Intellectual Property Litigation - http://delawareintellectualproperty.foxrothschild.com/
Judge Connolly Issues Claim Construction Opinion for Remaining Disputed Claim Term in Patent-in-Suit in Patent Infringement Action
12 Mar 2020, 2:36 pm by Gregory B. Williams
Connolly in Genentech, Inc. et al. v. [read post]
Delaware Intellectual Property Litigation - http://delawareintellectualproperty.foxrothschild.com/
Judge Connolly Denies Defendant’s Motion to Amend Answer to Add Affirmative Defense that Patent-in-Suit is Unenforceable Due to Plaintiff’s Inequitable Conduct Before the PTO
14 Feb 2020, 12:00 pm by Gregory B. Williams
Connolly in Genentech, Inc. et al. v. [read post]
Delaware Intellectual Property Litigation - http://delawareintellectualproperty.foxrothschild.com/
USPTO Guidelines: Amgen is a Nothingburger
11 Jan 2024, 12:59 pm by Dennis Crouch
Guidelines for Assessing Enablement in Utility Applications and Patents in View of the Supreme Court Decision in Amgen Inc. et al. v. [read post]
Patently-O - https://patentlyo.com
Patent Law at the Supreme Court February 2022
24 Feb 2022, 6:12 pm by Dennis Crouch
Daktronics, Inc., et al., No. 21-438 (CVSG requested October 4, 2021); and Appellate Standing for IPR Challenger: Apple Inc. v. [read post]
Patently-O - http://patentlyo.com/patent
Patent Law at the Supreme Court December 2021
14 Dec 2021, 9:57 am by Dennis Crouch
There are two other eligibility cases pending: Yanbin Yu, et al. v. [read post]
Patently-O - http://patentlyo.com/patent
Overreaching in patent claims dooms Gevo in district court. No infringement because of estoppel and invalidity through lack of enablement.
6 Aug 2013, 8:36 am by Lawrence B. Ebert
See Southwall Tech., Inc. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
Pharma & Biotech Global Week in Review 11 May 2011 from IP Think Tank
11 May 2011, 4:54 am by Marie Louise
Allergan, Inc. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
IP Think Tank Global Week in Review - 8 February 2008
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
IP Think Tank Global Week in Review - 2 May 2008
2 May 2008, 7:00 am
: (Patent Baristas), US: How to avoid a permanent injunction: the lessons of Amgen v Hoffman-LaRoche: (Patent Docs), US: Jarvik Heart’s PTE request based on PMA shell/module submission dates flatlines; ruling on initiation of PTE ‘review period’ mirrors FDA policy for ‘fast track’ products: (FDA Law Blog) Pharma & Biotech - Products Kytril (Granisetron) – Exclusivity ‘parking’… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog